{"generic":"Aminolevulinic Acid","drugs":["Aminolevulinic Acid","Levulan Kerastick"],"mono":{"0":{"id":"ju2bs0","title":"Generic Names","mono":"Aminolevulinic Acid"},"1":{"id":"ju2bs1","title":"Dosing and Indications","sub":{"0":{"id":"ju2bs1b4","title":"Adult Dosing","mono":"<ul><li><b>Actinic keratosis:<\/b> apply TOPICALLY to target lesion(s) on face or scalp and let dry, then repeat once; 14 to 18 hr later, gently rinse area with water and pat dry; follow by 1000 sec of illumination from the BLU-U(R) Blue Light Photodynamic Therapy Illuminator; may retreat a second time after 8 wk<\/li><li><b>Actinic keratosis:<\/b> protect treated lesions from sunlight or prolonged or intense light for at least 40 hr by covering with light-opaque material; sunscreen will not protect against photosensitivity reactions caused by visible light<\/li><\/ul>"},"1":{"id":"ju2bs1b5","title":"Pediatric Dosing","mono":"safety and effectiveness have not been established in children under 18 years of age "},"3":{"id":"ju2bs1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Actinic keratosis<br\/><b>Non-FDA Labeled Indications<\/b><ul><li>Basal cell carcinoma of skin<\/li><li>Squamous cell carcinoma<\/li><\/ul>"}}},"3":{"id":"ju2bs3","title":"Contraindications\/Warnings","sub":[{"id":"ju2bs3b9","title":"Contraindications","mono":"<ul><li>Cutaneous photosensitivity at wavelengths of 400 to 450 nanometers<\/li><li>Patients with porphyria<\/li><li>Allergies to porphyrins<\/li><li>Sensitivity to any of the components of the Levulan(R)  Kerastick(TM) for topical solution<\/li><\/ul>"},{"id":"ju2bs3b10","title":"Precautions","mono":"<ul><li>Do not apply to eyes or mucous membranes<\/li><li>Avoid exposure of treated areas to sunlight or bright indoor light  prior to blue light treatment; Sunscreens will NOT protect the patient from photosensitivity reactions<\/li><li>Avoid application of solution to perilesional areas; excessive irritation may occur if applied under occlusion<\/li><li>Possibility of increased photosensitivity reaction when used  concomitantly with other known photosensitizing agents<\/li><\/ul>"},{"id":"ju2bs3b11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"ju2bs3b12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"ju2bs5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Bleeding (mild or moderate, 2% to 4%; severe, 0%), Disorder of skin pigmentation (22% to 36%), Edema (35%), Erythema (99%), Flare reaction (mild or moderate, 2% to 7%; severe, 0% to 1%), Pruritus (mild or moderate, 14% to 25%; severe, 1% to 7%), Pustule (0% to 4%), Scaly skin (mild or moderate, 64% to 71%; severe, 1% to 2%), Sensation of burning of skin, Skin ulcer (mild or moderate, 2% to 4%; severe, 0%), Stinging of skin, Superficial ulcer of skin, Skin erosion (mild or moderate, 2% to 14%; severe, 0% to 1%), Vesicular eruption (mild or moderate, 4% to 5%; severe, 0%)<br\/>"},"6":{"id":"ju2bs6","title":"Drug Name Info","sub":{"0":{"id":"ju2bs6b17","title":"US Trade Names","mono":"Levulan Kerastick<br\/>"},"2":{"id":"ju2bs6b19","title":"Class","mono":"Photosensitizing Agent<br\/>"},"3":{"id":"ju2bs6b20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"ju2bs6b21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"ju2bs7","title":"Mechanism Of Action","mono":"aminolevulinic acid (ALA) is a prodrug which is metabolized to the photosensitizer, protoporphyrin IX (PpIX), causing it to accumulate intracellularly in the skin where applied; light excitation of PpIX in the presence of oxygen causes a photodynamic reaction, resulting in a local cytotoxic effect <br\/>"},"8":{"id":"ju2bs8","title":"Pharmacokinetics","sub":{"0":{"id":"ju2bs8b23","title":"Absorption","mono":"Bioavailability: (oral, solution), 50% to 60% <br\/>"},"2":{"id":"ju2bs8b25","title":"Metabolism","mono":"<ul><li>Hepatic; extent unknown<\/li><li>Active metabolite: protoporphyrin IX, in the skin<\/li><\/ul>"},"4":{"id":"ju2bs8b27","title":"Elimination Half Life","mono":"<ul><li>Aminolevulinic acid: (oral) 0.7 h, (IV) 0.83 h<\/li><li>Protoporphyrin IX: (topical, solution) 30 h (lesions), 28 h (perilesional skin)<\/li><\/ul>"}}},"9":{"id":"ju2bs9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>with the applicator cap pointing up, crush the bottom ampule, then crush the top ampule and continue crushing downward; point the applicator cap away from the face and gently shake the applicator for at least 30 sec to completely dissolve the drug<\/li><li>complete solution application within 2 hr of preparation and discard applicator; use new applicator if application is not complete within 2 hr<\/li><li>do not apply or allow contact to the periorbital, ocular, or mucosal surfaces<\/li><li>not recommended to treat both the face and scalp areas simultaneously<\/li><li>following application, do not wash the areas prior to photosensitization<\/li><li>at light illumination, rinse area with gently with water and pat dry<\/li><li>photoactivation is accomplished with a 1000 sec exposure to blue light (to provide a 10 Joules\/square centimeter light dose) with a BLU-U(R) Blue Light Photodynamic Therapy Illuminator, 14 to 18 hr after application of the solution<\/li><li>after photosensitization, protect treated lesions from sunlight or prolonged or intense light for at least 40 hr by covering with light-opaque material; sunscreen will not protect against photosensitivity reactions caused by visible light<\/li><\/ul>"},"11":{"id":"ju2bs11","title":"How Supplied","mono":"<b>Levulan Kerastick<\/b><br\/>Topical Stick: 20 %<br\/>"},"13":{"id":"ju2bs13","title":"Clinical Teaching","mono":"<ul><li>Instruct patient to avoid exposure of treated areas to sunlight or bright indoor light prior to the blue light treatment, as this may cause a photosensitivity reaction. Sunscreen will not protect patient from this reaction.<\/li><li>This drug may cause erythema, flare reaction, pruritus, skin stinging, or superficial ulceration of the skin.<\/li><\/ul>"}}}